Please enable Javascript
Uromigos-ASCO 2023-Bladder Cancer
Episode 242: ASCO 2023 - The THOR Study: Erdafitinib vs Chemotherapy in Bladder Cancer
The Uromigos
The Uromigos
|
July 17, 2023
Yohann Loriot, MD, PhD, discusses the practice-changing THOR study data on the benefit of erdafitinib for advanced UC.
Listen Now
Episode 246: ASCO 2023 - EV Pembrolizumab and Erdafitinib Cetrelimab in First-line UC
The Uromigos
The Uromigos
|
July 10, 2023
Shilpa Gupta, MD discusses two oral abstracts from ASCO 2023 on the CONTACT-03 trial and the EV-103 trial.
Listen Now
Advertisement
Advertisement